TY-51469 | m-entrepreneurship.com

Product Name :
TY-51469

Search keywords :
TY-51469

drugId :
null

Target Vo:
Chymase

Target Vo Short Name :
CMA1

Moa_Name:
Chymase inhibitors

First Approval Country :

First Approval Date Filter:
null

Origin Company_Name :
Toa Eiyo Ltd

Active Company_Name :

Active Indication_Name:

In Active Indication_Name:
Post-surgical adhesions

Termination Status :
Preclinical

China Termination Status :

Highest Status:
Pending

China Highest Status:

Antibodies are immunoglobulins secreted by effector lymphoid B cells into the bloodstream. Antibodies consist of two light peptide chains and two heavy peptide chains that are linked to each other by disulfide bonds to form a “Y” shaped structure. Both tips of the “Y” structure contain binding sites for a specific antigen. Antibodies are commonly used in medical research, pharmacological research, laboratory research, and health and epidemiological research. They play an important role in hot research areas such as targeted drug development, in vitro diagnostic assays, characterization of signaling pathways, detection of protein expression levels, and identification of candidate biomarkers.
Related websites: https://www.medchemexpress.com/antibodies.html
Popular product recommendations:
MEK1 Rabbit mAb Biological Activity
AIF (YP4062) Mouse mAb Purity & Documentation
p53 Antibody (YA250): p53 Antibody (YA250) is a non-conjugated and Rabbit origined monoclonal antibody about 44 kDa, targeting to p53. It can be used for WB,ICC/IF,IHC-P,IP assays with tag free, in the background of Human.

Author: Betaine hydrochloride

Related Posts